Abstract. An increasing number of infants and children undergo surgery and are exposed to anesthesia as a part of medical care each year. Isoflurane is a commonly used anesthetic in the pediatric population. However, previous studies have reported widespread isoflurane-induced neuroapoptosis and cognitive impairments in neonatal animal models, raising concerns over the administration of isoflurane in the pediatric population. The current study investigated the effects of rutin, a flavonoid, on isoflurane-induced neuroapoptosis in a neonatal rodent model. Groups of neonatal rat pups were administered rutin at doses of 10, 20 or 40 mg/kg body weight from postnatal day 1 (P1) to P15. On P7, pups were exposed to 0.75% isoflurane for 6 h. Rat pups in the control groups did not receive rutin, and did not receive anesthesia in one group. Neuroapoptosis following isoflurane exposure was determined by TUNEL assay. The expression levels of cleaved caspase-3, apoptotic pathway proteins [Bcl2-associated agonist of cell death (Bad), phospho-Bad, Bax, B-cell lymphoma 2 (Bcl-2) and Bcl-xL and mitogen-activated protein kinases (MAPK)] signalling pathway proteins [c-Jun N-terminal kinase (JNK), phospho-JNK, extracellular-signal-regulated kinase 1/2 (ERK1/2), phosphoERK1/2, p38, phospho-p38 and phospho-c-Jun], were determined by western blot analysis. The Morris water maze test was used to assess the learning and memory of pups on P30 and P31. The present study found that rutin at the tested doses of 10, 20 and 40 mg significantly reduced (P<0.05) the isoflurane-induced elevation in apoptotic cell count. The expression levels of caspase-3, Bad, Bax and MAPK proteins, which were increased following isoflurane treatment, were rescued by rutin treatment. Furthermore, rutin prevented the increase in Bcl-xL, Bcl-2 and phospho-Bad expression following isoflurane treatment, and enhanced the memory of the rats. Rutin provided neuroprotection against isoflurane-induced neuronal apoptosis and improved the learning and memory of rats by effectively regulating the expression levels of proteins in the MAPK pathway.
Introduction
Volatile anesthetics such as isoflurane and sevoflurane are used in pediatric surgical procedures and in imaging studies (1) . Extended exposure to volatile anesthetics causes widespread neurodegeneration in the developing brains of animals, and also results in persistent learning and memory deficits (2-7). Children <4 years of age who have undergone surgery under general anesthesia more than once have a greater likelihood of developing cognitive disabilities and also experience difficulties in reading and learning (8, 9) . Previous studies have raised serious concerns regarding the safety of such anesthetics, and have therefore necessitated protective strategies (2, 3, 8, 9) .
Isoflurane has been reported to induce neuroapoptosis and degeneration by [Ca 2+ ] i overload (10, 11) , which subsequently activates the mitochondrial pathways of apoptosis (12, 13) , and has also been demonstrated to be associated with the activation of c-Jun N-terminal kinase (JNK) (4) . JNK is a member of the mitogen activated protein kinases (MAPKs). MAPKs are a family of serine-threonine protein kinases that consist of three major members: Extracellular-signal-regulated kinases (ERKs), p38 MAPK and JNK. MAPK signalling pathways serve important roles in cell survival, development, neurodegeneration, pain and inflammation under normal and pathological conditions (14) (15) (16) (17) . The JNK signalling cascade involves mediating neuronal apoptosis through the regulation of Bcl-2 family members and activation of c-Jun (18) , resulting in indirect transcriptional regulation of the Bcl-2 family members (19) , including downregulation of the anti-apoptotic proteins (19, 20) .
Recent studies have revealed that the involvement of MAPK cascades in anesthetics-induced neurotoxicity. Li et al (7) reported the involvement of the JNK pathway in isoflurane-induced neurodegeneration in the hippocampi of neonatal rats. Furthermore, N-stearoyl-l-tyrosine was reported to protect the developing brain against sevoflurane-induced neurotoxicity via the ERK1/2 signalling pathway (21) . Finally, Sanders et al (22) reported that dexmedetomidine upregulated ERK1/2 in brain tissues of neonatal rats exposed to isoflurane.
Rutin is a flavonoid glycoside found in numerous plants including buckwheat, limes, oranges, grapefruit and berries. Numerous pharmacological properties of rutin, including antioxidant (23), anti-inflammatory (24) and hypolipidemic properties (25) have been reported. The present study endeavoured to investigate the role of rutin in terms of providing neuroprotection against isoflurane-induced neuroapoptosis in the hippocampi of neonatal rats through the modulation of MAPK cascades.
Materials and methods
Reagents and chemicals. Isoflurane (0.75%) and rutin were purchased from Sigma-Aldrich (Merck Millipore, Darmstadt, Germany). Antibodies against cleaved caspase-3, Bcl2-associated agonist of cell death (Bad), phospho-Bad, Bcl-xL, Bax, β-actin, JNK, phospho-JNK, phospho-c-Jun, ERK1/2, phospho-ERK1/2, p38 and phospho-p38 were purchased from Cell Signalling Technology (Danvers, MA, USA). All the chemicals used in the current study were of analytical grade and purchased from Sigma-Aldrich, unless otherwise specified.
Animals. The present study was approved (approval no. HAU24677244) by the Animal Care and Ethical Committee of Huazhong Agriculture University (Wuhan, China) and was performed in accordance with the National Institutes of Health Guide for the Use of Laboratory Animals (26) . A total of 12 pregnant female Sprague-Dawley rats (Guangdong Medical Laboratory Animal Center, Guandong, China) were used in this study, and were maintained in an environment with a 12 h light/dark cycle and a room temperature of 22±1˚C (humidity, 55-60%). Animals were provided with ad libitum access to water and food and were housed individually in separate cages and monitored closely from the day of birth [postnatal day 0 (P0)]. Pups were then carefully maintained with their littermates in a standard environment, as outlined, with a 12 h light/dark cycle and free access to water. A total of 60 pups (n=12/group) weighing 18-28 g were used for the experiments. Pups in the treatment groups were administered rutin [10, 20 or 40 mg/kg body weight (b.wt)] orally, once every day from P1, and treatment was continued until P15 in addition to a standard diet. Control group pups did not receive rutin or isoflurane. Separate group of rat pups that were exposed only to isoflurane served as the anesthetic control.
Exposure to anesthesia. A total of 60 pups (n=12/group) were assigned into groups as follows: Group 1, control pups, not treated with anesthetic or rutin; group 2, anesthetic control, exposed to isoflurane (0.75%) for 6 h (7,27) and not treated with rutin; group 3, treated with 10 mg/kg rutin and exposed to isoflurane on P7; group 4, treated with 20 mg/kg rutin and exposed to isoflurane on P7; and group 5, treated with 40 mg/kg rutin and exposed to isoflurane on P7. On P7, 1 h prior to the delivery of isoflurane, rutin was administrated. At the end of the 6th hour of anesthetic exposure, six rat pups (n=6) from each experimental group were sacrificed and their brains were excised. For sacrifice, within 1 h of anesthesia, pups were perfused transcardially with ice-cold saline followed by 4% paraformaldehyde in 0.1 M phosphate buffer The hippocampi of the rat pups were then used for protein expression analysis by western blotting and TUNEL assay. The remaining rats (n=6) continued to receive rutin supplementation until P15, and were then maintained according to the standard experimental conditions until P31. Rats were subjected to memory and learning studies via Morris Water Maze tests.
TUNEL assay. TUNEL studies were performed as described previously by Li et al (7) . Briefly, rat pups that were anesthetized with isoflurane were perfused transcardially with ice-cold saline, followed by 4% paraformaldehyde in 0.1 M phosphate buffer. The brain tissues were harvested and post-fixed in formaldehyde for 48 h at 4˚C, embedded in paraffin and sectioned (5 µm thickness). TUNEL positive cells were determined using the Dead End fluorometric TUNEL System kit (Promega Corporation, Madision, WI, USA) and positive cell counts in the hippocampal CA1, CA3 and DG regions were analyzed with an inverted Eclipse Ti2 microscope and NIS-Elements BR imaging processing and analysis software (Nikon Corporation, Tokyo, Japan).
Western blot analysis. Western blot analysis was performed to assess the expression levels of various proteins following isoflurane exposure and rutin treatment. Western blot analysis was performed as previously described by Li et al (6, 7) . Briefly, protein concentrations were determined using a BCA protein assay (Bio-Rad Laboratories, Inc., Hercules, CA, USA). Each of the protein samples (60 µg) was separated by 12% polyacrylamide gel electrophoresis, blotted on a nitrocellulose membrane and hybridized using the following antibodies: Anti-Bad (1:1,000; 9268), anti-phospho-Bad (1:1,000; 5284), anti-Bcl-xL (1:2,000; 2764), anti-cleaved caspase-3 (1:2,000; 9661), anti-Bax (1:1,000; 5023), anti-Bcl-2 (15071; 1:1,000), anti-ERK1/2 (1:1,000; 9102), anti-phospho-ERK1/2 (1:1,000; 9101), anti-JNK (1:1,000), anti-phospho-JNK (1:1,000; 9255), anti-phospho-c-Jun (1:1,000; 3270), anti-β-actin (1:2,000; 3700), anti-p38 (1:1,000; 8690) and phospho-p38 (1:1,000; 4511). The immunoreactive bands were observed using an ECL detection kit (RPN2232) and images were scanned using Image Master 2D Platinum 7.0 scanner (both GE Healthcare, Pittsburgh, PA USA). Images were analyzed by ImageQuant TL software v2003.03 (version .8.3; GE Healthcare). The band signals of the proteins were normalized relative to β-actin bands.
Memory and learning studies Morris water maze test.
To assess the effects of rutin on isoflurane-induced alterations in memory and learning, spatial reference memory and learning assessments, including the Morris water maze test, were performed as previously described by Li et al (28) .
The rat pups exposed to isoflurane and/or rutin were trained in the Morris water maze for 4 days between P26 and P29. A platform of ~10 cm in diameter was submerged in a circular pool (200 cm in diameter, 60 cm depth) filled with warm water (23±2˚C). The rats were subjected to 2 sessions per day. Animals were allowed 60 sec to locate the hidden platform, and if unable to locate it within 60 sec, they were gently guided. All trials and swim paths were recorded with ANY-maze Video Tracking system (Stoelting Co., Wood Dale, IL, USA), which measured the time taken (latency) to find the platform(s), as well as other behavioral information obtained during the spatial reference memory test. Subsequent to the trials, each rat was placed in a holding cage under an infrared heat lamp prior to being returned to its regular cage.
Cued trials. Cued trials were conducted on P31 to assess any non-cognitive performance impairments such as visual impairments and/or swimming difficulties. The pool was covered with a white cloth to conceal the visual cues. The rats undertook four trials per day. In each trial, they were placed in a particular section of the swimming pool towards the wall and were then allowed to swim to a platform with a rod that served as a cue. The rod was placed 20 cm above water level in a random position in any of the four quadrants of the swimming pool. The rat pups were given 60 sec to locate the platform and 30 sec to sit on the platform, after which they were removed from the pool. The rats that failed to locate a platform within 60 sec were gently guided toward it and allowed to remain there for 30 sec. The time taken by each rat to reach the cued platform was recorded and analyzed.
Place trials. Subsequent to the cued trials, the white curtains that surrounded the pool were removed and the same rats were assessed in place trials to determine their ability to understand the spatial relationship between distance cues and the escape platform (no cue rod), that was placed in one of the four quadrants and remained in the same position for all place trials. The starting points were random for each rat. The time taken to reach the platform was recorded.
Probe trials. In order to assess the memory of rat pups, probe trials were conducted 24 h after place trials. The submerged platform was removed and the rats were placed in the opposite quadrant and allowed to swim for 60 sec. The time each rat spent in each quadrant whilst attempting to locate the platform was recorded. The data are expressed as the percentage of time spent by the animals in each of the quadrants.
Statistical analysis.
All values are presented as the mean ± standard deviation of three or six individual experiments. Multiple group comparisons were performed using one-way analysis of variance, followed by Duncan's multiple range test. The analysis was performed using SPSS statistical software (version 17.0; SPSS, Inc., Chicago, IL, USA).P<0.05 was considered to indicate a statistically significant difference.
Results

Rutin treatment reduces isoflurane-induced neuroapoptosis.
Isoflurane, a commonly used volatile anesthetic, induces neuroapoptosis and long-term cognitive dysfunction in developing animals (4, 5, 12) . In the present study, apoptosis was evaluated by TUNEL assay following isoflurane exposure in P7 rat pups. The delivery of 6 h of isoflurane exposure significantly raised the proportion of TUNEL-positive cells in CA1, CA3 and in the dentate gyrus (DG) regions (P<0.05). The increases were more pronounced in the DG region when compared with the CA1 and CA3 regions. Rutin (10, 20 or 40 mg/kg b.wt) pre-treatment significantly reduced (P<0.05) the TUNEL-positive cell counts in a dose-dependent manner, as compared to the isoflurane-only group (Fig. 1) .
Rutin regulates the expression levels of apoptotic cascade proteins. To further assess apoptosis, quantification of cleaved caspase-3 protein expression was performed by western blot analysis. Endogenous levels of activated caspase-3 are a known and useful marker of neuronal apoptosis (29) . Caspase-3 is a key cell death marker and apoptosis effector enzyme (29, 30) . The current study revealed that isoflurane significantly induced caspase-3 activation (P<0.05; Fig. 2A and B) . However, rutin significantly downregulated (P<0.05) caspase-3 expression levels, with the 40 mg dose presenting a more marked reduction compared with the isoflurane group. The lower dose of rutin (10 mg) reduced caspase-3 expression levels; however the reduction was not statistically significant.
Furthermore, isoflurane treatment alone resulted in the decreased expression of Bcl-xL and Bcl-2, the anti-apoptotic proteins in the hippocampi of P7 rats, but upregulated the expression of Bax, a protein that promotes apoptosis by binding to and antagonizing the Bcl-2 protein (20) . In the present study, the increase in Bax expression correlated with the downregulation of Bcl-2, supporting this conclusion. Isoflurane however, decreased phospho-Bad expression levels, yet the total expression levels of Bad increased compared with the control group. A significant decrease in the Bcl-xL/Bad ratio was observed following isoflurane exposure compared with the control group (P<0.05; Fig. 2C ). Rutin at all the doses significantly ameliorated (P<0.05) the alteration in expression levels of the studied proteins ( Fig. 2B and C) . Rutin significantly upregulated (P<0.05) Bcl-xL and Bcl-2 expression levels and downregulated Bax expression levels compared with the isoflurane group. The phosphorylation of Bad has an anti-apoptotic effect, whereas its de-phosphorylation is pro-apoptotic (20) . The increased levels of total Bad observed following isoflurane exposure were significantly reduced by treatment with rutin (P<0.05), suggesting the effectiveness of rutin for inhibiting isoflurane-induced neuroapoptosis.
Neuroprotection by rutin involves MAPK signalling cascades.
To further evaluate the molecular effects of rutin on MAPK pathway proteins, the expression levels of major MAPK proteins, including JNK, ERK and p38, were analyzed by western blotting (Fig. 3A) . Exposure to isoflurane for 6 h caused a significant increase in the phosphorylated JNK, ERK1/2 and p38 levels (P<0.05; Fig. 3B ). The expression levels of total JNK, ERK1/2 and p38 were also significantly increased (P<0.05). However, rutin exposure resulted in significant reductions (P<0.05) in the elevated levels of phospho-JNK and phospho-c-Jun compared with the isoflurane-treated group. The administration of 40 mg/kg b.wt rutin caused a significant suppression (P<0.05) in the phosphorylated forms of ERK1/2 and p38 in a dose-dependent manner. The administration of 40 mg rutin resulted in similar protein expression levels to those of pups in the control group that were not exposed to anesthesia, which is suggestive of its protective capacity against isoflurane-induced alterations of protein expression (Fig. 3) .
Effects of rutin on the behavior and memory of rats exposed to inhalation anesthesia.
To evaluate the effect of neonatal exposure to isoflurane on potential learning and memory deficits, animals were subjected to the Morris water maze test, the main test used to assess spatial learning and memory (31) . The rat pups exposed to isoflurane anesthesia were trained to explore the swimming pool and to reach the platform. The escape latency, which is the duration each rat takes to reach the submerged platform, was recorded. The latency was observed to decrease with each training session for all rats irrespective of whether they had been administered isoflurane and rutin or isoflurane alone (Fig. 4) . The escape latencies of rutin administered groups were found to be similar to control values.
Cued trials were conducted on P31 to evaluate the swimming and visual abilities of the rat pups. The rats exposed to isoflurane anesthesia took significantly longer to reach the submerged platform compared with pups that received A B no anesthesia (P<0.05; Fig. 5 ). Rutin supplementation was observed to significantly improve the performance of the rats (P<0.05). The animals that received rutin were able to reach the platform quicker compared with the rats that received isoflurane alone. Furthermore, the rats that received the higher dose of rutin (40 mg/kg b.wt) reached the platform in a shorter time compared with those that received lower doses in the cued and place trials (Fig. 5 ). Place and probe trials were performed to assess the ability of the rat pups to learn and remember the location of a new platform (Fig. 5) . In place trials, the rats that received 20 and 40 mg/kg b.wt rutin exhibited a significant improvement in performance (P<0.05), as compared with the isoflurane-only group. The rutin (20 and 40 mg)-treated rats reached the platform quicker. The 10 mg/kg b.wt dose did not elicit an enhancement in the performance of the rats. The memory retention following exposure to isoflurane on P7 was assessed by removing the platform from the pool. Isoflurane exposure had a significantly detrimental impact on the memory of the rats compared with the control group (P<0.05; Fig. 5 ), as determined by the time the animals spent in the target quadrant. The rats exposed to isoflurane spent less time in the target quadrant compared with the control group, which was indicative of the memory and learning deficits caused by isoflurane. The rats that were administered rutin spent more time on the target quadrant searching for the platform compared with the isoflurane group (P<0.05), indicating that there was an improvement in the memory of Figure 5 . Learning and memory of the rat pups following anesthesia exposure on P7 as determined by cued, place and probe trials using the Morris water maze. On P30 and P31, rats were assessed for their learning and working memory capacities. Rutin administration markedly improved the performance of the rats. Values are represented as mean ± standard deviation, n=6. rat pups with 40 mg/kg b.wt dose of rutin compared wuth rat pups who received isoflurane alone.
Discussion
Previous studies have demonstrated the potential detrimental effects of anesthetic exposure to neonatal animals in terms of causing neurohistopathological changes and long-term behavior deficits and cognitive dysfunctions (6, 32, 33) . Apoptotic cell death is an essential part of normal brain development and maturation, leading to the elimination of ~50-70% of neurons and progenitor cells during the development of the central nervous system (34, 35) . However, during pathological processes such as hypoxia-ischemia, an absence of neurotrophic factors, or prolonged exposure to anesthetic, the rate of apoptosis surpasses the normal apoptotic rate (36, 37) .
Isoflurane, a commonly used volatile anesthetic, has been reported to induce neurodegeneration in the developing brain of animal models (2, 4, 5, 7) . The present study focused on an analysis of the effects of flavonoid rutin on isoflurane-induced neurotoxicity.
The present study demonstrated that there was an increased level of apoptosis in the brain tissues of neonatal rats exposed to 0.75% isoflurane for 6 h. Although anesthetic-induced neurotoxicity is widespread throughout brain tissue, the current study observed the effects on the hippocampal region, as previous reports have suggested that hippocampal lesions following isoflurane exposure result in abnormal behavioral responses in neonatal rats (2, 3, 5, 38) . Increased apoptotic cell counts that were observed in the CA1, CA3 and DG regions of the hippocampus following isoflurane exposure were significantly reduced with rutin treatment, demonstrating the neuroprotective effects of rutin. Previous studies have suggested that neurogenesis in the DG region is important to hippocampus-dependent episodic learning and memory, and any interference in the process may result in impaired hippocampal learning (39, 40) .
Furthermore, the raised cleaved caspase-3 expression was found to be consistent with TUNEL-positive cell counts as a result of anesthetic exposure. Caspase-3 serves a vital role in the apoptotic pathway (41) , and in previous studies, cleaved caspase-3 expression levels were used as a marker of apoptotic cell death (2, 4, 5, 33) . Rutin effectively downregulated the expression levels of activated caspase-3, in addition to the apoptotic cell count. Furthermore, the expression levels of Bax protein were upregulated following exposure to isoflurane. The anti-apoptotic protein Bcl-xL is widely expressed in the central nervous system, which enhances cell survival by maintaining mitochondrial membrane integrity and inhibits the release of cytochrome c (42) .
The Bcl-2 gene family encodes proteins that regulate the apoptosis program. The Bcl-2 family includes the pro-apoptotic (Bax and Bak) and anti-apoptotic (Bcl-2 and Bcl-xL) members (20) . The delicate balance of the Bcl-2 family determines the release of cytochrome c, in addition to the subsequent activation of the caspase cascade, leading to apoptosis (19, 20) . In the present study, isoflurane decreased the expression levels of Bcl-2, Bcl-xL and phospho-Bad. However, the elevated levels of total Bad observed following isoflurane exposure may have caused the decrease in the Bcl-xL/Bad ratio. The current results demonstrated that rutin effectively reversed the isoflurane-induced downregulation of Bcl-2, Bcl-xL and phospho-Bad, and improved the Bcl-xL/Bad ratio, which may contribute to the stabilization of the inner mitochondrial membrane, and thus inhibit isoflurane-induced neuroapoptosis.
The MAPK pathway has been reported to be involved in anesthetic-induced neurodegeneration (7, 21) . The JNK signalling pathway is involved in neuronal apoptosis triggered by several brain injury stimuli, such as ischemic reperfusion injury (43) (44) (45) . Previous studies have demonstrated that the activation of JNK signalling is involved in isoflurane-induced neuronal apoptosis (7) . Activated JNK phosphorylates a nuclear substrate, the transcription factor c-Jun, which results in an increase of activator protein-1 transcription activity to modulate the transcription of genes associated with apoptosis. By contrast, activated JNK regulates the activation of non-nuclear substrates, including Bcl-2 family members (43, 45) .
The present results indicated that rutin pretreatment inactivated the JNK nuclear pathway by reducing the isoflurane-induced increase in the phosphorylation of JNK and transcription factor c-Jun. Rutin also inhibited the JNK non-nuclear pathway by preventing the isoflurane-induced downregulation of Bcl-2, and increasing the expression levels of Bax. Furthermore, rutin caused a marked decrease in the expression levels of phospho-ERK1/2 that had been upregulated following exposure to isoflurane, which was similar to the protective effect observed with dexmedetomidine (22) . Zheng and Zuo (46) reported that isoflurane activated p38 MAPK in the brains of rats. The current study reported an increase in the activation of p38 following the exposure of neonatal rats pups to isoflurane on P7. However, rutin decreased phospho-p38 expression levels in a dose-dependent manner. Rutin (40 mg/kg b. wt) resulted in the regulation of the expression patterns of the MAPK pathway proteins compared with lower doses. These results suggest the potential involvement of the MAPK signalling pathway in both isoflurane-induced neuronal apoptosis, and in the neuroprotection caused by rutin.
Several studies have reported deficits in learning and memory in rodents after neonatal exposure to volatile anesthetics (2, 3) . Working memory refers to cognitive functions that provide synchronized temporary storage and manipulation of the information required to perform intricate cognitive tasks. Working memory is involved in higher cognitive functioning such as planning and sequential behavior. Any deficits in the working memory are directly associated with deficits in behavioral flexibility, and learning deficits have been shown to be associated with hippocampal damage (47) .
The Morris water maze test was selected to evaluate the cognitive behavior of rat pups as it is a reliable measure of hippocampus-dependent spatial navigation and reference memory (48) . The escape latencies demonstrated by the rats that received isoflurane was significantly longer compared with the controls when assessed ~4 weeks after the administration of isoflurane. The observations of the present study are suggestive of the possibility of impairments with respect to long-term memory caused by exposure to isoflurane. This could be attributed to the observed isoflurane-induced neurodegeneration. Jevtovic-Todorovic et al (2) reported that, on P7, rats are extremely sensitive to neurotoxic challenge. Thus, any decrease in neural cell proliferation in neonates may eventually lead to cognitive dysfunction by disrupting the neural architecture of the hippocampus during a critical period of development, or by depleting the pool of precursor cells present throughout the duration of the animal's life (49) .
The marked reduction in neuronal apoptosis as a result of treatment with rutin may have contributed to the significant improvements observed in the performance of the rats in the Morris water maze tests when comparing the isoflurane-only and rutin-treated groups. This may also improve the working memory of the rats.
In conclusion, rutin effectively reduced neuronal apoptosis by regulating JNK/ERK/p38MAPK signalling pathways and modulating the expression of apoptotic proteins. Thus, additional exploration of the effects of rutin is warranted to identify its molecular targets, which may elucidate anesthetic-induced neuronal toxicities.
